# Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

> **NCT05383300** · NA · COMPLETED · sponsor: **King's College London** · enrollment: 72 (actual)

## Conditions studied

- Antisocial Personality Disorder

## Interventions

- **DRUG:** Oxytocin nasal spray
- **OTHER:** Placebo spray

## Key facts

- **NCT ID:** NCT05383300
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2022-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05383300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05383300, "Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05383300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*